An earnout is a contingent purchase price mechanism in a merger or acquisition. The buyer pays part of the consideration at closing and agrees to pay more later if the acquired business hits defined post-closing targets. For finance professionals, earnouts matter because they change headline valuation, shift risk between buyer and seller, and often raise the odds of post-closing disputes. In practice, they also affect underwriting, lender protections, and how management behaves after close.
The structure appears most often when current performance is visible but forward performance is genuinely disputed. Founder-led businesses, healthcare services platforms, software companies with concentrated bookings, roll-ups with run-rate adjustments, and carve-outs where standalone earnings are hard to verify all fit that profile. By contrast, an earnout is much less useful when post-closing integration will materially change the target’s cost base or revenue mix, because integration makes clean measurement difficult.
An earnout is not seller financing. A seller note creates a fixed obligation subject to credit risk. An earnout creates a conditional obligation tied to a defined metric or event. It is also not rollover equity, which exposes the seller to the buyer’s broader platform value rather than a contractual test for the sold business.
Earnouts are a standard feature of private M&A, not an exception. SRS Acquiom reported earnouts in 26% of surveyed private-target deals signed in 2024, and the ABA’s 2025 Private Target M&A Deal Points Study points in the same direction. Those figures are best treated as directional, not universal, because middle-market studies tend to overrepresent negotiated sponsor and strategic transactions rather than the full deal universe.
The commercial logic is straightforward. Sellers use an earnout to defend headline value when buyers will not pay the full price at signing. Buyers use it to defer payment until performance is proven. However, lenders and investment committees should stay skeptical. An earnout often postpones the valuation argument rather than solving it, and it can create incentives that conflict with integration, cost rationalization, and leverage reduction.
The first question is not how to draft the earnout. The first question is what risk is actually being transferred. Sometimes the issue is real uncertainty, such as revenue conversion, regulatory approval, customer retention, or a new site ramp. Sometimes the issue is that the seller’s price case depends on aggressive EBITDA adjustments.
That distinction matters because earnouts work better for the first category than the second. If the disagreement is really about quality of earnings, working capital normalization, or customer concentration, contingent price may obscure the risk instead of allocating it. That is a poor answer if you are defending an entry multiple to an investment committee, building a credit case, or trying to support a valuation that must survive scrutiny later.
A useful rule of thumb is simple. If the disputed value driver can be observed cleanly after closing, an earnout may help. If it will be buried inside accounting judgments, buyer integration choices, or noisy adjustments, the structure is likely to disappoint.
Revenue-based earnouts are usually the easiest to measure. They are common when margins are volatile, accounting policies differ between buyer and seller, or the buyer plans meaningful investment after closing. The problem is economic, not technical. Revenue can reward unprofitable growth, which matters if you are modeling returns or setting lender protections.
EBITDA or profit-based earnouts try to align value with cash generation. They also create the most disputes. Shared services allocations, integration costs, management fees, transfer pricing, synergies, and discretionary capex can all move the number. Unless the acquired business stays ring-fenced operationally, EBITDA-based tests are hard to administer and can make integration more adversarial.
Milestone-based earnouts are event-driven. Typical triggers include regulatory clearance, a product launch, execution of a key customer contract, or opening a facility. These structures work best when the milestone is binary, verifiable, and largely within the seller team’s control. That is why they fit life sciences, healthcare, and early-stage technology better than heavily integrated industrial deals.
Hybrid earnouts combine milestone and financial tests, or stack multiple periods with graduated payouts. They can reflect how value is actually created, but each extra metric adds another path to dispute. Complexity is rarely a virtue here.
For finance teams, the key modelling point is expected value. Bankers often present “up to” consideration that includes the full earnout. Your model should not. Instead, probability-weight the payout and show the bridge from headline value to expected value. If the trigger depends on buyer-controlled decisions or ambitious assumptions, the gap between those two figures may be wide. That gap belongs in the IC memo, not in a footnote.
An earnout should appear in the model as both a valuation issue and a behavior issue. At minimum, analysts should test payout probability, timing, and the effect on returns if the metric is partially achieved. If the earnout uses revenue, test what happens when bookings rise but margins fall. If it uses EBITDA, test whether cost allocations or integration charges can swamp the target’s standalone progress.
A simple example shows why precision matters. Assume a buyer pays $80 million at closing and agrees to pay up to $20 million over two years if the business reaches $30 million and then $36 million in revenue, with $10 million due at each threshold. If the buyer later bundles products and changes revenue recognition for implementation services, the same commercial performance may produce a very different reported number. The problem is not arithmetic. The problem is that the earnout no longer measures what the parties thought they priced.
A junior banker, private equity associate, or private credit underwriter can spot trouble early by asking a few direct questions before drafting gets elaborate:
If two or more answers are weak, the earnout is probably bridging a valuation gap on paper while creating execution risk in reality. In that case, cleaner structures may be better.
The most important drafting issue for practitioners is not legal style. It is measurement discipline. Five points need little room for interpretation: what is being measured, over what period, under which accounting rules, with what exclusions or adjustments, and who controls the operating decisions that affect the result.
Revenue definitions should state gross versus net treatment, returns, rebates, discounts, intercompany sales, deferred revenue recognition, and the treatment of acquisitions completed during the earnout period. EBITDA definitions should also state whether accounting principles are fixed at closing or can follow the buyer’s evolving policies. A practical structure is a hierarchy of terms, specific definitions first, examples second, and a principles clause third, so inconsistent application is easier to challenge.
Reporting discipline matters just as much. Monthly reporting is appropriate for short earnouts, while quarterly reporting may work for longer periods. If the metric is EBITDA-like, the package should identify cost allocations, one-time charges, and related-party items. This is one reason good earnout design should be tied back to the quality of earnings work and the target’s historical reporting package before signing.
Accounting treatment can move reported earnings even when cash does not move. Under ASC 805, contingent consideration is recognized at fair value on the acquisition date and later remeasured through earnings if it is classified as a liability. IFRS 3 is broadly similar. That classification matters because liability-classified earnouts can create non-cash income statement volatility and complicate leverage discussions, especially if lenders treat them as debt-like.
Tax can also change the economics. If part of the earnout is tied to the seller staying employed after closing, authorities may view those payments as compensation rather than purchase price. That can trigger withholding, payroll tax obligations, and different deduction timing for the buyer. The cleanest commercial takeaway is simple: employment-linked earnouts deserve extra scrutiny from the start.
Financing documents may be the most overlooked constraint. Credit agreements often restrict deferred consideration above negotiated baskets or allow payment only when no default exists. Sellers sometimes assume the earnout sits ahead of equity in a leveraged deal. In reality, the payment may be blocked by covenant tests or liquidity limits. For private credit teams, that means earnouts can behave like junior debt, blocked debt, or future litigation exposure, depending on structure. That is why they should be reviewed alongside the direct lending case and the wider capital structure.
Alternatives often work better when the disputed value driver is not cleanly measurable or is too exposed to buyer control. A seller rollover, minority retained stub, consulting arrangement tied to specific deliverables, customer-retention escrow, or plain closing price with tighter purchase price protections may deliver a better outcome with less friction. This is especially true in deals with immediate post-merger integration, where standalone observability disappears fast.
The practical test is whether the earnout improves risk-adjusted entry price or simply adds another source of conflict. If the answer is the latter, move on. An earnout should narrow a measurable disagreement, not paper over a weak underwriting case. Teams running a buy-side process should be disciplined about that distinction.
An earnout in M&A works best when the value driver is observable, time-bound, and not heavily shaped by post-close buyer decisions. For finance professionals, the real edge comes from treating the earnout as an underwriting problem first and a drafting problem second: model expected value, test management incentives, tie definitions back to actual reporting, and assume complexity will cost more than it looks like at signing.
P.S. – Check out our Premium Resources for more valuable content and tools to help you break into the industry.
